Minjae Shin

Chief Executive Officer at Kaigene.

Raised on Kaigene filings

$55M

of $73.3M offered across 1 Form D filing

Company

Biotech · Rockville, MD

Antibody drugs that degrade disease-causing autoantibodies

Antibody drugs that degrade disease-causing autoantibodies

Kaigene Form D filings
Filed	Security	Sold of offered	Filing
Oct 14, 2026	Equity	$55M/ $73.3M	Form D

Also named on Kaigene filings